GWS
WST icon

Glassman Wealth Services’s West Pharmaceutical WST Stock Holding History

Glassman Wealth Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-128
Closed -$45.1K – 1846
2023
Q4 		$45.1K Buy
128
+6
+5% +$2.12K 0.01% 473
2023
Q3 		$45.8K Sell
122
-3
-2% -$1.16K 0.01% 445
2023
Q2 		$47.8K Hold
125
– – 0.01% 418
2023
Q1 		$43.3K Buy
125
+6
+5% +$1.75K 0.01% 440
2022
Q4 		$28K Buy
119
+1
+0.8% +$237 0.01% 572
2022
Q3 		$29K Sell
118
-28
-19% -$8.53K 0.01% 524
2022
Q2 		$44K Buy
146
+49
+51% +$15.9K 0.01% 426
2022
Q1 		$40K Buy
97
+17
+21% +$6.66K 0.01% 462
2021
Q4 		$38K Buy
80
+7
+10% +$3.01K 0.01% 438
2021
Q3 		$31K Buy
73
+4
+6% +$1.69K 0.01% 470
2021
Q2 		$25K Buy
69
+4
+6% +$1.32K 0.01% 518
2021
Q1 		$18K Buy
65
+8
+14% +$2.29K ﹤0.01% 563
2020
Q4 		$16K Buy
57
+12
+27% +$3.37K ﹤0.01% 601
2020
Q3 		$12K Buy
45
+22
+96% +$5.82K ﹤0.01% 581
2020
Q2 		$5K Buy
23
+13
+130% +$2.55K ﹤0.01% 643
2020
Q1 		$2K Sell
10
-28
-74% -$4.31K ﹤0.01% 766
2019
Q4 		$6K Buy
38
+5
+15% +$728 ﹤0.01% 565
2019
Q3 		$5K Hold
33
– – ﹤0.01% 550
2019
Q2 		$4K Buy
33
+3
+10% +$354 ﹤0.01% 612
2019
Q1 		$3K Buy
30
+5
+20% +$520 ﹤0.01% 653
2018
Q4 		$2K Hold
25
– – ﹤0.01% 583
2018
Q3 		$3K Hold
25
– – ﹤0.01% 561
2018
Q2 		$2K Hold
25
– – ﹤0.01% 593
2018
Q1 		$2K Buy
+25
New +$2.34K ﹤0.01% 564

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Glassman Wealth Services's WST Position: Q1 2024 in Review

Glassman Wealth Services sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 128 shares — an estimated $45.1K sold.

Glassman Wealth Services first reported a position in WST in Q1 2018 and held it in 24 quarters. The position peaked at $47.8K in Q2 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Glassman Wealth Services reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 128 West Pharmaceutical shares in Q1 2024, an estimated $45.1K.
  • Glassman Wealth Services first reported a position in West Pharmaceutical in Q1 2018 and held it in 24 quarters.
  • Glassman Wealth Services's West Pharmaceutical position peaked at $47.8K in Q2 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.